Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16492077 | 0.97 | BCHE (0.38) | BCHEMGLLTDP1MEN1KMT2A | |
| SCHEMBL21024930 | 0.82 | ALDH1A1 (0.36) | BCHEALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL23031896 | 0.81 | CTSK (0.36) | BCHEALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL16489892 | 0.81 | HPGD (0.55) | BCHEMGLLMEN1KMT2AALDH1A1 | |
| SCHEMBL20997933 | 0.80 | ALDH1A1 (0.34) | BCHEALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL21024929 | 0.78 | CTSK (0.33) | BCHEALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL13385071 | 0.77 | TDP1 (0.48) | TDP1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL1108679 | 0.77 | TDP1 (0.48) | TDP1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL13827403 | 0.77 | TDP1 (0.58) | TDP1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL157321 | 0.77 | TDP1 (0.58) | TDP1MEN1KMT2AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | ESD, ELL, ASH2L | BCHE 2128/4885MGLL 603/4885TDP1 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.